Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Cardiac Death

glucose, (beta-d)-isomer has been researched along with Cardiac Death in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (25.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	2 (50.00)	2.80

Authors

Authors	Studies
Demling, R; Ikegami, K; LaLonde, C; Nayak, U	1
Choi, YJ; Han, KD; Kim, BS; Kim, HK; Kim, YJ; Lee, H; Lee, HJ; Lim, J; Na, JO; Park, JB; Rhee, TM	1
Anker, SD; Brueckmann, M; Butler, J; Ferreira, JP; Filippatos, G; Jamal, W; Ofstad, AP; Packer, M; Pfarr, E; Pocock, SJ; Zannad, F	1
Everett, BM; Hiatt, WR	1

Reviews

2 review(s) available for glucose, (beta-d)-isomer and Cardiac Death

Article	Year
SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials. Lancet (London, England), 2020, 09-19, Volume: 396, Issue:10254 Topics: Aged; Angiotensin Receptor Antagonists; Benzhydryl Compounds; Body Mass Index; Case-Control Studies; Cause of Death; Clinical Trials as Topic; Death; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Glucosides; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Neprilysin; Patient Outcome Assessment; Sodium-Glucose Transporter 2 Inhibitors; Stroke Volume	2020
Finding Efficacy in a Safety Trial: Empagliflozin and Cardiovascular Death. Circulation, 2016, Sep-06, Volume: 134, Issue:10 Topics: Benzhydryl Compounds; Clinical Trials as Topic; Death; Drug Approval; Glucosides; Humans; Hypoglycemic Agents; Treatment Outcome	2016

Article

Year

SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials.

Lancet (London, England), 2020, 09-19, Volume: 396, Issue:10254

Topics: Aged; Angiotensin Receptor Antagonists; Benzhydryl Compounds; Body Mass Index; Case-Control Studies; Cause of Death; Clinical Trials as Topic; Death; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Glucosides; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Neprilysin; Patient Outcome Assessment; Sodium-Glucose Transporter 2 Inhibitors; Stroke Volume

2020

Finding Efficacy in a Safety Trial: Empagliflozin and Cardiovascular Death.

Circulation, 2016, Sep-06, Volume: 134, Issue:10

Topics: Benzhydryl Compounds; Clinical Trials as Topic; Death; Drug Approval; Glucosides; Humans; Hypoglycemic Agents; Treatment Outcome

2016

Other Studies

2 other study(ies) available for glucose, (beta-d)-isomer and Cardiac Death

Article	Year
Comparison between lung and liver lipid peroxidation and mortality after zymosan peritonitis in the rat. Shock (Augusta, Ga.), 1994, Volume: 2, Issue:3 Topics: Analysis of Variance; Animals; Carbon Dioxide; Death; Lipid Peroxidation; Liver; Lung; Male; Oxygen; Partial Pressure; Peritonitis; Rats; Rats, Wistar; Zymosan	1994
Comparative cardiovascular outcomes in type 2 diabetes patients taking dapagliflozin versus empagliflozin: a nationwide population-based cohort study. Cardiovascular diabetology, 2023, 07-26, Volume: 22, Issue:1 Topics: Benzhydryl Compounds; Cohort Studies; Death; Diabetes Mellitus, Type 2; Female; Glucosides; Heart Failure; Humans; Male; Middle Aged; Sodium-Glucose Transporter 2 Inhibitors	2023